Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

• Norio Sugawara ,

  * E-mail: nsuga3@yahoo.co.jp

  Affiliations Aomori Prefectural Center for Mental Health and Welfare, Aomori, Japan, Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan

  ⨯
• Masamichi Ishioka,

  Affiliation Department of Psychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan

  ⨯
• Shoko Tsuchimine,

  Affiliation Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan

  ⨯
• Koji Tsuruga,

  Affiliation Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan

  ⨯
• Yasushi Sato,

  Affiliation Department of Psychiatry, Seihoku-Chuoh Hospital, Goshogawara, Japan

  ⨯
• Hanako Furukori,

  Affiliation Department of Psychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan

  ⨯
• Shuhei Kudo,

  Affiliation Department of Psychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan

  ⨯
• Tetsu Tomita,

  Affiliation Department of Neuropsychiatry, Odate Municipal General Hospital, Odate, Japan

  ⨯
• Taku Nakagami,

  Affiliation Department of Neuropsychiatry, Odate Municipal General Hospital, Odate, Japan

  ⨯
• Norio Yasui-Furukori

  Affiliation Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan

  ⨯